News Detail
Related News
News Detail

Razi Institute Provides Antivenom in High-Risk Middle Eastern Regions

en-news,inner news,branches,Media reflections,Announcements,conferences,workshops,exhibitions,Seminars,Multimedia
Publish Date : 08:20 - 2025/2/19
: Reading Time
Dr. Morteza Taghizadeh Taranabi, a faculty member at Razi Vaccine and Serum Research Institute, announced the institute's plans to identify high-risk areas in the Middle East and secure antivenom supplies in collaboration with international organizations.

Speaking at the International Online Conference on Venomous Animals and Antivenom, Dr. Taghizadeh highlighted the serious challenges in providing antivenom in war-torn and neighboring regions. In recent years, Afghanistan has been struggling with a critical shortage of antivenom, the life-saving treatment for snake bites. Due to the absence of an effective distribution system, a significant portion of this essential medication is being smuggled into the country. This lack of coordination in the distribution of antivenom has resulted in numerous fatalities among those who fall victim to snake bites.

Experts stress the importance of establishing a well-organized distribution network to ensure that antivenom is accessible to those in need. In light of the growing crisis, there are calls for government intervention and support from international organizations to improve the healthcare system and secure adequate supplies of this vital treatment.

He stressed the necessity of international cooperation to address this crisis, stating that Razi Institute aims to become a reference center for antivenom production and supply in the Middle East. This center will be equipped to identify new venomous snakes, assess the quality of their toxins, and assist in providing antivenom to countries in need to ensure health and save lives.

New Comment :
Name: Email: Comment: